Welcome to Best Pharmacy at Havmeds! Go shopping!

Product ID: 483539

Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer

POZIO 8

Poziotinib has been tested in trials for Breast Cancer, Metastatic Breast Cancer, Increased Drug Resistance, Adenocarcinoma of the Lung Stage IV, and Adenocarcinoma of the Lung Stage IIIB, among other conditions.

Trade name
POZIO 8
Manufacturer
People's Pharmaceuticals
Main ingreadient
Poziotinib
Specification
8mg*56 Capsules
Logistics
Please negotiate the logistics method with customer service, customer service Whatsapp/Wechat
Reminder
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.
Promise

Authenticity guarantee

India Direct Mail

Privacy packaging

Pharmacy Direct

Quantity

Poziotinib is a quinazoline-based, orally available, irreversible pan-epidermal growth factor receptor (EGFR or HER) inhibitor that has anticancer potential. EGFR (HER1 or ErbB1), HER2, and HER4 are all inhibited by poziotinib when taken orally, which stops tumor cells from proliferating if these receptors are overexpressed or altered. EGFRs, which are cell surface receptor tyrosine kinases that are increased or changed in several cancer cell types, are essential for cell proliferation and survival. Poziotinib has been tested in trials for Breast Cancer, Metastatic Breast Cancer, Increased Drug Resistance, Adenocarcinoma of the Lung Stage IV, and Adenocarcinoma of the Lung Stage IIIB, among other conditions.
The standard dosage regimen is 16 mg once a day, with meals or on an empty stomach, continuously.
Related Products
Copyright 2023 havmeds.com. All Rights Reserved
Whatsapp
Call Us